Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.

Antiretroviral therapy helped people with the virus add years to their lives, but now scientists must address other issues of longevity.

Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.

The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.

Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.

A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.

It’s a lot easier to fight addiction when you have a stable place to live.

A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.

A new report warns the crisis could see a third wave if synthetic opioids continue to move into new U.S. markets.

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.